First of Its Kind Technology Reduces Stroke by More Than 60 Percent in Patients Undergoing Common Heart Procedure
5/2/18: The company reports during Stroke Awareness Month in the month of May, it is important for patients suffering from severe aortic stenosis who are considering TAVR to be aware that there is technology available to make their treatment safer and offer them peace of mind, if they are concerned about the risk of stroke.
Sentinel Cerebral Protection System Emerging as U.S. Standard of Care for Protecting the Brain from Risk of Stroke During Transcatheter Aortic Heart Valve Replacement
Since FDA clearance in June 2017, the Sentinel Cerebral Protection System, developed by Claret Medical, has become an emerging standard of care in the U.S. to protect patients from the risk of stroke by capturing and removing debris associated with transcatheter aortic heart valve replacement (TAVR) before it travels to the brain. The novel system, which has been shown to significantly reduce the risk of stroke in the first three days after TAVR by more than 60 percent, has been adopted by 50 U.S. centers as part of its controlled rollout. The technology has protected more than 5,500 patients worldwide to date.
Claret Medical® today announced several of the largest centers of excellence for transcatheter aortic valve replacement (TAVR) have now performed the first U.S. cases of protected TAVR with the newly FDA-cleared Sentinel Cerebral Protection System in the...